VACCELERATE Latest News
ECCMID 2024
27-30 April 2024 Barcelona, Spain
Upcoming VACCELERATE Webinar
Willingness of EU medical and paramedical students to participate in vaccine trials: A cross-sectional VACCELERATE study
Registration: https://uni-koeln.zoom.us/meeting/register/tJ0tcOigqTorE9XWzWi-EHZPdKrdO0ofaFqU#/registration
Identification of educational needs of Cypriot patients
The VACCELERATE Cyprus team wants to conduct a study (questionnaire) for the identification of patient advocacy groups educational needs in Cyprus. This study will help EUPATI (European Patient’s Academy on Therapeutic Innovation) Cyprus to create an educational lab based on the official guidelines of EUPATI (central).
Prof. Bruijning-Verhagen in Cyprus
It was a great pleasure to host the WP5 Leads of the VACCELERATE pan European Scientific Consortium, Professor Patricia Bruijning-Verhagen and Sanne Hofstraat from the UMC Utrecht, in Cyprus at the Medical School of the European University Cyprus.
The aim of the visit was to perform clinical site visits and interviews with local stakeholders across Cyprus to foster capacity building in the field of clinicaltrials in Cyprus. It was discussed about missed opportunities, the current barriers and possible #acilitators to improve the Cypriot clinical research ecosystem with concrete actions.
Survey to explore the willingness of future physicians and healthcare professionals
VACCELERATE has adapted a survey in an attempt to explore willingness of future physicians and healthcare professionals to contribute to advancements in healthcare by participating in COVID-19 vaccine trials. The objective is to understand the willingness of future healthcare professionals, across Europe, to participate in vaccine trials and provide valuable insights on the mindset of future physicians and healthcare providers.
To date over 600 responses have been recorded with Germany in the lead with 297 responses, followed by Sweden and then Cyprus. Understanding the willingness of this group will provide insights on the concerns and reluctance of participating in vaccine trials.
A press conference will be held on 29th September, 2023, to present the collective results gathered from a questionnaire designed by a collaboration between EUPATI Cyprus and European University Cyprus.
English version: https://forms.gle/E2NatNsAUGi3poYy9
Exciting news from Switzerland!
We're thrilled to announce our groundbreaking partnership with Working Bicycles, all while treading lightly on the ecological path. 🚴♂️ Pedaling Progress: Together for a greener world! At VACCELERATE, we are not just transforming lives and healthcare; we are doing it sustainably. Ready to be a part of this incredible journey?
Join us today at the Volunteer Registry and pedal your way to a brighter future!
VACCELERATE Volunteer Registry boost in Sweden
The Swedish VACCELERATE team has had a busy time working to engage more individuals in vaccine research. With the aim of boosting the number of registrations in the VACCELERATE registry, an ambitious new communications campaign was rolled out. This targeted a wide spectrum of characteristics and focused on generating a registry of high quality. With the assistance of the CO in Cologne, new materials were designed and printed.
Multiple channels were harnessed, including social media, advertising in private vaccination clinics, and targeted outreach to universities and companies. The result was a more than 300% increase in registrations – from 70 to 231.
VACCELERATE Webinar
VACCELERATE Volunteer Webinar December 11 2023
VACCELERATE Arzt-Patient:innen Webinar Wir sind erkältet und bald ist Weihnachten (in German)
We are very happy to announce that Module I of our Study Nurse Course is now online!
The course is designed for study/research nurses and will provide the needed expertise to conduct a clinical trial in line with the ICH GCP guidelines. Next to the regulatory background, the course also tackles and trains practical aspects necessary for the daily work of a study nurse. A well-trained trial centre is essential for the success of a clinical trial.
The total duration of the complete course (consisting of three modules) will provide learning material of about 30 hours (Module I: 9.5 hours). After each module, a certificate of completion can be downloaded.
More information: https://vaccelerate.eu/academy-2/
On January 25th 2023 the VACCELERATE team from Cyprus joined a EUPATI (https://www.eupati.eu/) meeting to support and enhance the role of patient advocacy groups in vaccine clinical research. They provided a gift with the VACCELERATE educational cards.
50,000th VACCELERATE Volunteer is honoured in Belgium:
VACCELERATE Newsletters
We are happy to send you the pdf versions of our newsletters including the links providing further information on the topics: info@vaccelerate.eu.
NEWSLETTER Issue I/2024
Published in March 2024.
NEWSLETTER Issue IV/2023
Published in December 2023.
NEWSLETTER Issue III/2023
Published in September 2023.
NEWSLETTER Issue II/2023
Published in June 2023.
NEWSLETTER Issue I/2023
Published in March 2023.
NEWSLETTER Issue III/2022
Published in December 2022.
NEWSLETTER Issue II/2022
Published in September 2022.
NEWSLETTER Issue I/2022
Published in July 2022.
VACCELERATE Press Releases
21.04.2024 / Preparando armas contra la proxima pandemia: https://www.pressreader.com/spain/el-mundo-primera-edicion-weekend-int/20240421/282076281922295
20.04.2024 / Next pandemic likely to be caused by flu virus, scientists warn: https://www.theguardian.com/world/2024/apr/20/next-pandemic-likely-to-be-caused-by-flu-virus-scientists-warn
19.01.2024 / VACCELERATE APT Workshop in Cologne: A paradigm shift towards a learning health system: https://twitter.com/vaccelerate_eu/status/1748405062714441795
12.01.2023 / Would You Take Part in A Clinical Vaccine Trial? A Survey on COVID-19 Vaccine Trial Participation by the EU-funded project VACCELERATE: Willingness to participate in COVID-19 vaccine trials (cleoresearch.org)
19.09.2022 / VACCELERATE Network Supports Diagnostics and Treatment of Monkeypox: https://twitter.com/vaccelerate_eu/status/1571924880295084033
29.08.2022 / Lietuvoje jau veikia VACCELERATE savanorių dalyvauti klinikiniuose tyrimuose registras: https://www.santa.lt/lietuvoje-jau-veikia-vaccelerate-savanoriu-dalyvauti-klinikiniuose-tyrimuose-registras/
25.08.2022 / First children participate in UMC Utrecht-led study: Is one COVID-19 vaccination dose enough for kids? https://twitter.com/vaccelerate_eu/status/1562848995793596416
28.07.2022 / The VACCELERATE Volunteer Clinical Trial Registry is launched in Italy: https://twitter.com/vaccelerate_eu/status/1556578444850434055
21.07.2022 / How many COVID-19 infections are there in Germany? Pilot study in Cologne investigates high dark figure: https://twitter.com/vaccelerate_eu/status/1550014216635023360 (German translation: https://twitter.com/CornelyOliver/status/1550015496413745152)
15.03.2022 / VACCELERATE study on the effectiveness of a second booster shot begins in Ireland: https://twitter.com/vaccelerate_eu/status/1503688207506063360
22.02.2022 / Karolinska Universitetssjukhuset söker fler deltagare i kampen mot framtida pandemier: Karolinska Universitetssjukhuset söker fler deltagare i kampen mot framtida pandemier – Karolinska Universitetssjukhuset (cision.com)
16.02.2022 / Wer sollte wann weiteren Booster bekommen?: https://www.uk-koeln.de/de/uniklinik-koeln/aktuelles/detailansicht/wer-sollte-wann-weiteren-booster-bekommen/
05.11.2021 / Studie zur Wirksamkeit der „Boosterimpfung“ gegen Corona startet: https://portal.uni-koeln.de/universitaet/aktuell/presseinformationen/detail/studie-zur-wirksamkeit-der-boosterimpfung-gegen-corona-startet
22.07.2021 / Coronavirus: Commission steps up research funding with €120 million for 11 new projects to tackle the virus and its variants (European Commission): https://ec.europa.eu/commission/presscorner/detail/en/IP_21_3803
12.04.2021 / Cologne’s university medicine to coordinate EU vaccine research network (Coimbra Group): https://newsletters.coimbra-group.eu/t/ViewEmail/j/4AD409F80C7A2CCF2540EF23F30FEDED/4013911B0F09E5BE4AB3169DA1FD82E9
16.03.2021 COMBACTE To Support Vaccine Trial Network VACCELERATE (Combacte): https://www.combacte.com/news/combacte-support-vaccine-trial-network-vaccelerate/
15.03.2021 / 12 Million for European COVID-19 Vaccine Research (Combacte): https://www.combacte.com/news/12-million-european-covid-vaccine-research/
18.02.2021 / Neues Konsortium koordiniert EU-Impfstoff-Forschungsnetzwerk: https://www.uk-koeln.de/uniklinik-koeln/aktuelles/detailansicht/neues-konsortium-koordiniert-eu-impfstoff-forschungsnetzwerk/
18.02.2021 / Cologne’s university medicine to coordinate EU vaccine research network VACCELERATE (CECAD): https://www.cecad.uni-koeln.de/about/news/article/colognes-university-medicine-to-coordinate-eu-vaccine-research-network-vaccelerate/
17.02.2021 / EU to invest €150 million for research to counter coronavirus variants (European Commission): https://ec.europa.eu/info/news/eu-invest-eu150-million-research-counter-coronavirus-variants-2021-feb-17_en
VACCELERATE Press Review
29.09.2023 / Παρουσίαση αποτελεσμάτων έρευνας από το Eupati Cyprus και το European University με στόχο την ανίχνευση των εκπαιδευτικών αναγκών των ασθενών στην Κύπρο (ANT Live): https://www.ant1live.com/koinonia/562456_paroysiasi-apotelesmaton-ereynas-apo-eupati-cyprus-kai-european-university-me-stoho
29.09.2023 / Παρουσίαση αποτελεσμάτων έρευνας από το Eupati Cyprus και το European University με στόχο την ανίχνευση των εκπαιδευτικών αναγκών των ασθενών στην Κύπρο (Cyprus News): https://cyprusnews.live/article/202463
29.09.2023 / Οι εκπαιδευτικές ανάγκες των ασθενών στην Κύπρο-Τι κατέδειξε έρευνα (In Business News): https://inbusinessnews.reporter.com.cy/article/2023/9/29/734787/oi-ekpaideutikes-anagkes-ton-asthenon-sten-kupro-ti-katedeixe-ereuna/
23.12.2022 / Johanna Massy (64) is 50.000ste vrijwilliger bij Vaccinopolis: “Door deel te nemen hoop ik de wetenschap vooruit te helpen” (HLN): https://www.hln.be/edegem/johanna-massy-64-is-50-000ste-vrijwilliger-bij-vaccinopolis-door-deel-te-nemen-hoop-ik-de-wetenschap-vooruit-te-helpen~affc3851/?referrer=https%3A%2F%2Fmedialibrary.uantwerpen.be%2F
23.11.2022 / Výzkumná síť VACCELERATE: staňte se součástí výzva registru dobrovolníků (MUNI MED): https://www.med.muni.cz/aktuality/vyzkumna-sit-vaccelerate-stante-se-soucasti-vyzva-registru-dobrovolniku
10.10.2022 / Corona-Pandemie wurde zum Booster für Vakzinologie (K.AT News): https://k.at/news/corona-pandemie-booster-fuer-vakzinologie/402175785
20.09.2022 / Η Ελλάδα στον χάρτη των κλινικών δοκιμών εμβολίων κατά της CoViD (Iatronet): https://www.iatronet.gr/article/111645/h-ellada-ston-harth-ton-klinikon-dokimon-emvolion-kata-ths-covid
28.07.2022 / Nasce in Italia „VACCELERATE“, il registro degli studi clinici volontari: Verona è capofila nazionale (Mattino Verona): https://www.mattinodiverona.it/2022/07/28/nasce-in-italia-vaccelerate-il-registro-degli-studi-clinici-volontari-lunivr-riferimento-nazionale-del-progetto/
28.07.2022 / Partecipare a studi su prodotti anti-pandemie, al via registro volontari (Lafreccia): https://www.lafrecciaweb.it/2022/07/28/partecipare-a-studi-su-prodotti-anti-pandemie-al-via-registro-volontari-progetto-ue-parte-anche-in-italia-universita-verona-centro-di-riferimento-nazionale/
28.07.2022 / Nasce in Italia „VACCELERATE“, il registro degli studi clinici volontari: Verona è capofila nazionale (In salute news): https://www.insalutenews.it/in-salute/nasce-in-italia-vaccelerate-il-registro-degli-studi-clinici-volontari-universita-di-verona-riferimento-nazionale/
28.07.2022 / Covid: attivo in Italia registro volontari „VACCELERATE“ Database permette di aderire a progretti sul vaccino (Federfarma): https://federfarma.it/Edicola/Ansa-Salute-News/VisualizzaNews.aspx?type=Ansa&key=33884
28.07.2022 / Partecipare a studi su prodotti anti-pandemie, al via registro volontari (Corriere Del Umbria): https://corrieredisiena.corr.it/news/adnkronos/32566212/partecipare-a-studi-su-prodotti-anti-pandemie-al-via-registro-volontari.html
28.07.2022 / L'università di Verona riferimento nazionale del Registro degli studi clinici volontari „VACCELERATE“ (Primoweb): https://primoweb.it/luniversita-di-verona-riferimento-nazionale-del-registro-degli-studi-clinici-volontari-vaccelerate/
28.07.2022 / Arriva in Italia registro die volontari per participare a studi clinici sui vaccini (Veronasera): https://www.veronasera.it/attualita/registro-volontari-vaccini-vaccelerate-28-luglio-2022.html
28.07.2022 / Partecipare a studi su prodotti anti-pandemie, al via registro volontari (Olbia Notizie): https://www.olbianotizie.it/24ore/articolo/632005-partecipare_a_studi_su_prodotti_anti_pandemie_al_via_registro_volontari
28.07.2022 / Partecipare a studi su prodotti anti-pandemie, al via registro volontari (Tiscali News): https://notizie.tiscali.it/salute/articoli/partecipare-studi-prodotti-anti-pandemie-via-registro-volontari-00001/?chn
28.07.2022 / Partecipare a studi su prodotti anti-pandemie, al via registro volontari (Affaritaliani): https://www.affaritaliani.it/rubriche/tuttasalute/notiziario/partecipare-a-studi-su-prodotti-anti-pandemie-al-via-registro-volontari-277113.html
28.07.2022 / Nasce in Italia „VACCELERATE“, il registro degli studi clinici volontari: Verona è capofila nazionale (A Salute & Benessere): https://www.larena.it/rubriche/salute-e-benessere/nasce-in-italia-vaccelerate-il-registro-degli-studi-clinici-volontari-verona-e-capofila-nazionale-1.9543801
26.07.2022 / UMC Utrecht is investigating whether one corona jab in children works just as well as two (Time.News): https://time.news/umc-utrecht-is-investigating-whether-one-corona-jab-in-children-works-just-as-well-as-two/
26.07.2022 / Onderzoek naar 1 of 2 coronaprikken bij kinderen (UMC Utrecht): https://www.umcutrecht.nl/nieuws/onderzoek-naar-1-of-2-coronaprikken-bij-kinderen
27.03.2022 / Antibodies could determine fourth vaccine eligibility – study: https://www.rte.ie/news/coronavirus/2022/0327/1288742-coronavirus-antibodies/
24.01.2022 / VACCELERATE: Volunteer Registry: A European Study Participant Database to Facilitate Clinical Trial Enrolment (THE LANCET Preprint): https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4016606
06.01.2022 / Nach dem Booster: Brauchen wir bald noch eine vierte Impfung gegen Corona? (Kölner Stadt-Anzeiger): https://www.ksta.de/ratgeber/gesundheit/nach-dem-booster-brauchen-wir-bald-noch-eine-vierte-impfung-gegen-corona–39359316
19.12.2021 / Die Vierte Impfung. Impfstoff gegen Omikron (Zeit): https://www.zeit.de/gesundheit/2021-12/omikron-variante-impfstoff
13.12.2021 / Mehrere Impfversuche bei initialen Non-Respondern machen“ (Ärzteblatt): https://www.aerzteblatt.de/nachrichten/129957/Mehrere-Impfversuche-bei-initialen-Non-Respondern-machen
08.12.2021 / Interview with Zoi D. Pana about the situation in Cyprus and the VACCELERATE network (Offsite): https://www.offsite.com.cy/eidiseis/topika/pana-gia-vaccelerate-den-kanei-toys-anthropoys-peiramatozoa
03.12.2021 / Interview with Oliver Cornely and Zoi D. Pana (Alpha Channel CY): https://twitter.com/vaccelerate_eu/status/1468558210437165059
23.11.2021 / Interview „Seit März 2020 im Lockdown“ (Kölner Stadt-Anzeiger): Print
15.11.2021 / Lietuvoje pradėtas COVID-19 stiprinamosios vakcinos dozės tyrimas (Lrytas): https://www.lrytas.lt/it/laboratorija/2021/11/15/news/lietuvoje-pradetas-covid-19-stiprinamosios-vakcinos-dozes-tyrimas-21407670
15.11.2021 / Pradėtas COVID-19 stiprinamosios vakcinos dozės tyrimas (Santaros Klinikos): https://www.santa.lt/naujienos/pradetas-covid-19-stiprinamosios-vakcinos-dozes-tyrimas/
12.11.2021 / Studie untersucht Booster-Effekt (Kölnische Rundschau): Print
12.11.2021 / Uni Köln Studie untersucht Booster-Effekt der Corona-Impfungen (Kölnische Rundschau): Uni Köln: Studie untersucht Booster-Effekt der Corona-Impfungen | Kölnische Rundschau (rundschau-online.de)
09.11.2021 / Studie zur Wirksamkeit der Booster-Impfung (Frankfurt Live): https://www.frankfurt-live.com/studie-zur-wirksamkeit-der-booster-impfung-136942.html
08.11.2021 /Neue Studie startet in Köln Wie gut sind Booster-Impfungen wirklich? (Kölner Stadt-Anzeiger): https://www.ksta.de/koeln/neue-studie-startet-in-koeln-wie-gut-sind-booster-impfungen-wirklich–39112684
03.11.2021 / Alle Infos zur Auffrischung Wann kann ich mir die Booster-Impfung gegen Corona holen? (Kölner Stadt-Anzeiger): Booster-Impfung: Wer braucht die dritte Impfdosis? | Kölner Stadt-Anzeiger (ksta.de)
26.10.2021 / Nach Kimmich-Aussage Was Experten zu Langzeitfolgen der Corona-Impfung sagen (Kölner Stadt-Anzeiger): https://www.ksta.de/ratgeber/gesundheit/nach-kimmich-aussage-was-experten-zu-langzeitfolgen-der-corona-impfung-sagen-39087508
25.10.2021 / Uniklinik Köln sucht Probanden für Drittimpfung (WDR): TV
13.10.2021 / Studie zur Wirksamkeit der Booster-Impfung (Radio Köln): Radio
28.09.2021 / Zu langsam, zu mühsam, zu wenig (SZ): Print
27.09.2021 / Der geringe Beitrag der deutschen COVID-19-Forschung (Tagesspiegel): Print
16.07.2021 / ECCMID 2021 TV: Talking trials with Oliver Cornely (ECCMID TV): https://www.youtube.com/watch?v=cKRC_2wYXEU
10.07.2021 / Hunderte Kölner trotz zweiter Impfung infiziert (Kölner Stadt-Anzeiger): Print
09.07.2021 / Zu wenig Antikörper? Was wir über die COVID-19-Todesfälle bei geimpften Kölnern wissen? (Kölner Stadt-Anzeiger)
30.06.2021 / Coronavirus: Government advisor part of €12m grant for Covid vaccine research (Cyprus Mail): https://cyprus-mail.com/2021/06/30/coronavirus-government-advisor-part-of-e12m-grant-for-covid-vaccine-research/
27.05.2021 / Aufholjagd: Das europäische Impfstoff-Netzwerk Vaccelerate (ARTE): https://www.arte.tv/de/videos/104080-000-A/aufholjagd-das-europaeische-impfstoff-netzwerk-vaccelerate/
12.05.2021 / Expert says at least one booster vaccine shot necessary (in-Cyprus): https://in-cyprus.philenews.com/expert-says-at-least-one-booster-vaccine-shot-necessary/
11.04.2021 / Pulse of Europe Rheinland: „Europa – Gesundheitspolitik für eine krisenfeste Zukunft?“ (Event): https://www.youtube.com/watch?v=NLR-ELvSyxo
14.03.2021 / 11.111 – VACCELERATE Volunteer Registry (Kölner Universitätsmagazin): https://portal.uni-koeln.de/universitaet/aktuell/koelner-universitaetsmagazin/unimag-einzelansicht/11111
VACCELERATE-related Scientific Publications
04.04.2024 / Perspectives of European Patient Advocacy Groups on Volunteer Registries and Vaccine Trials: VACCELERATE Survey Study (JMIR): https://publichealth.jmir.org/2024/1/e47241
22.12.2023 / Immunogenicity, Reactogenicity and Safety of a Second Booster with BNT162b2 or Full-Dose mRNA-1273: A Randomised VACCELERATE Trial in Adults ≥75 Years (EU-COVAT-1-AGED Part B) (Preprints with The Lancet): https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4671824
06.12.2023 / Predicting the next pandemic: VACCELERATE ranking of the World health Organization's Blueprint for action to prevent epidemics (Travel Medicine and Infectious Disease): https://www.sciencedirect.com/science/article/pii/S1477893923001369
29.11.2923 / The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach Communities: An Internal Expert Consultation of the VACCELERATE Consortium (vaccines): https://www.mdpi.com/2076-393X/11/12/1784/htm
02.11.2023 / Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time (nature communications): https://www.nature.com/articles/s41467-023-42717-1.pdf
31.10.2023 / Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1) (Vaccine): https://www.sciencedirect.com/science/article/pii/S0264410X23012136
27.10.2023 / Epidemiology of Acute Respiratory Infection with SARS-CoV-2, Influenza A & B Viruses, Respiratory Syncytial Virus, and Adenovirus in VACCELERATE Volunteers in Germany (Preprints with THE LANCET): https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4612721
01.09.2023 / Factors that impact on recruitment to vaccine trials in the context of a pandemic or epidemic: a qualitative evidence synthesis (Cochrane Library): https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000065.pub2/full
18.05.2023 / VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe (Vaccine): https://www.sciencedirect.com/science/article/pii/S0264410X23005236
03.04.2023 / Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit (JMIR Publications): https://publichealth.jmir.org/2023/1/e44491
07.12.2022 / Efficacy and safety of COVID‐19 vaccines (Cochrane Library): https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015477/epdf/full
11.2022 / Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination (Journal of Immunological Methods): https://www.sciencedirect.com/science/article/pii/S0022175922001326
10.2022 / Monkeypox diagnostic and treatment capacity at epidemic onset: A VACCELERATE online survey (Journal of Infection and Public Health): https://www.sciencedirect.com/science/article/pii/S1876034122002118?via%3Dihub
08.10.2022 / A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network (Trials): https://pubmed.ncbi.nlm.nih.gov/36209129/
04.10.2022 / Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2 (eBioMedicine): https://pubmed.ncbi.nlm.nih.gov/36206622/
19.09.2022 / Monkeypox in children and adult women in Europe: Results from a flash VACCELERATE pilot survey (Enfermedades Infecciosas y Microbiología Clínica): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534071/
31.08.2022 / Vaccination rates in Europe are not associated with online media intensity (JCOM Journal of Science Communication): https://jcom.sissa.it/archive/21/05/JCOM_2105_2022_A05
18.06.2022 / A pilot surveillance report of SARS-CoV-2 rapid antigen test results among volunteers in Germany, 1st week of July 2022 (Infection): https://link.springer.com/article/10.1007/s15010-022-01931-7
13.06.2022 / Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR (Nature Biotechnology): https://www.nature.com/articles/s41587-022-01347-6
02.06.2022 / VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment (Vaccine): https://www.sciencedirect.com/science/article/pii/S0264410X22006053?via%3Dihub
05.04.2022 / A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern (Communications Medicine): https://www.nature.com/articles/s43856-022-00091-x
23.03.2022 / Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination (Frontiers in Immunology): https://www.frontiersin.org/articles/10.3389/fimmu.2022.845882/full
11.01.2022 / Factors that impact on recruitment to vaccine trials during a pandemic or epidemic: a qualitative evidence synthesis (Cochrane Library): https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000065/full
04.10.2021 / Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days (Frontiers in Immunology): https://www.frontiersin.org/articles/10.3389/fimmu.2021.726960/full
03.08.2021 / Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals (Cell Reports): https://www.cell.com/cell-reports/fulltext/S2211-1247(21)01004-4?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2211124721010044%3Fshowall%3Dtrue
29.07.2021 / Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 (The Lancet Infectious Diseases): https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00420-5/fulltext
27.05.2021 / Reactogenicity and Immunogenicity of BNT162b2 in Subjects Having Received a First Dose of ChAdOx1s: Initial Results of a Randomised, Adaptive, Phase 2 Trial (CombiVacS) (The Lancet): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233007/
VACCELERATE Events
KIT 2023 / VACCELERATE Talks and Posters
14-17 June 2023
16th Congress for Infectious Diseases and Tropical Medicine
Leipzig, Germany
Pint of Science / VACCELERATE Talk
24 May 2023, 19.00 Die Tankstelle, Kyffhäuser Str. 19 50674, Cologne
Tickets (only 2.5€): https://pintofscience.de/event/from-ancient-potatoes-to-future-computers
SCT 44th Annual Meeting
21-24 May 2023 Baltimore, USA
Public Health Conference Timisoara, Romania
11-13 May 2023
Organized by the Regional Center of Public Health Timisoara, EPIVEST Association and the University of Medicine and Pharmacy Timisoara.
The conference targeted public health specialists from the regional public health authorities, medical schools and hospitals.
https://epivest.ro/conferinta-nationala-de-sanatate-publica-tm-2023/
CECAD Open Day
06 May 2023, 10.00-17.00
Visit our VACCELERATE booth, special campagin with the Vacuna vaccination app (https://vacuna.io/)
Programme: https://www.cecad.uni-koeln.de/tag-der-alternsforschung
ECCMID 2023
33rd European Congress of Clinical Microbiology & Infectious Diseases
15 – 18 April 2023 Copenhagen, Denmark
2nd VACCELERATE Annual Meeting 16 MARCH 2023
1st Scientific Meeting of the National CY Vaccination Committee
22 October 2022, Cyprus
MYK 2022
12-14 September 2022 Vienna, Austria
CZECRIN Annual Research Conference 2022
09 JUNE 2022 Brno, Czech Republic
International Clinical Trials Day (ICTD) 2022
17 MAY 2022 Berlin, Germany
FAMHP Vaccine Symposium
10 May 2022
Prof. Pierre Van Damme presenting VACCELERATE in his talk „Perspective for the future: Vaccinopolis and biopreparedness initiative“
40th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID)
09-13 MAY 2022 Athens, Greece
World Vaccine Day 14 MAY 2022
On World Vaccine Day people around the world celebrate the benefits of vaccines. This day aims to raise awareness of the many positive contributions that vaccines make to our society.
More information on https://worldvaccineday.org/.
23-26 APRIL 2022
32nd European Congress of Clinical Microbiology & Infectious Diseases, Lisbon, Portugal
1st Cypriot-Greek VACCELERATE Volunteer Registry Webinar with local National Patient Advocacy Groups 28 MARCH 2022
– To seek the support of PAG Members in completing the VAC PAG questionnaire (perspectives of PAGs for participation in clinical trials and volunteer registries)
– To invite them to join the VACCELERATE Volunteer Registry by becoming volunteers in our Cypriot Greek VAC platforms More than 12 PAGs participated
You can watch the video of the webinar (in Greek) here: https://www.youtube.com/watch?v=DNFNVe17mtg
The First World Conference Fighting COVID-19 Pandemic Health Challenges
26-28 MARCH 2022, Belgrade, Serbia.
VACCELERATE talk: Jon Salmanton-García: VACCELERATE: The pan-European backbone for the acceleration of phase 2 & 3 COVID-19 vaccine trials
1st VACCELERATE Annual Meeting 09-10 MARCH 2022
With a keynote lecture by top leading expert Stephen Lockhart from Pfizer:
Vaccine Clinical Trials: Key Factors for Success – BNT162 as an Example.
